Sean Zheng
Director/Board Member en NOVABAY PHARMACEUTICALS .
Fortuna: 90 $ al 31/03/2024
Perfil
Sean Zheng is currently the Chief Executive Officer at Q3 Medical Devices Shanghai Co. Ltd.
and also serves as the Director at NovaBay Pharmaceuticals, Inc. starting from 2022.
Previously, he worked as a Director at Dingtian Asset Management Co., Ltd.
from 2007 to 2011 and as a Managing Director at Boill Fund Management Hk Co. Ltd.
He holds an MBA from The University of New South Wales (2002) and China Europe International Business School (2010) and an undergraduate degree from Renmin University of China (1992).
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/04/2024 | 858 ( 0.00% ) | 90 $ | 31/03/2024 |
Cargos activos de Sean Zheng
| Empresas | Cargo | Inicio |
|---|---|---|
| NOVABAY PHARMACEUTICALS | Director/Board Member | 27/01/2022 |
| Q3 Medical Devices Shanghai Co. Ltd. | Chief Executive Officer | - |
Antiguos cargos conocidos de Sean Zheng.
| Empresas | Cargo | Fin |
|---|---|---|
| Dingtian Asset Management Co., Ltd. | Director/Board Member | 01/01/2011 |
| Boill Fund Management Hk Co. Ltd. | Chief Executive Officer | - |
Formación de Sean Zheng.
| The University of New South Wales | Masters Business Admin |
| China Europe International Business School | Masters Business Admin |
| Renmin University of China | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NOVABAY PHARMACEUTICALS | Health Technology |
| Empresas privadas | 3 |
|---|---|
| Dingtian Asset Management Co., Ltd. | |
| Q3 Medical Devices Shanghai Co. Ltd. | |
| Boill Fund Management Hk Co. Ltd. |
- Bolsa de valores
- Insiders
- Sean Zheng
